Optimeos Life Sciences

Altamira Therapeutics

This company develops peptide-based nanoparticle technologies for RNA delivery to pharmaceutical industry partners developing treatments for cancer and inflammatory diseases.

Spot Biosystems

This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.

Hone Bio

This company develops lipid nanoparticle targeting technology for pharmaceutical and biotechnology firms to enable precise drug delivery beyond the liver.

Aera Therapeutics

This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.

Nanograb

This company develops an artificial intelligence platform to design targeted gene delivery vectors and nanoparticles for pharmaceutical organisations developing genetic medicines.

Nuntius Therapeutics

This company develops mRNA and gene-editing therapies using a programmable nanocarrier delivery platform for pharmaceutical companies and research institutions.

NanoSyrinx

NanoSyrinx develops synthetic nanosyringes for targeted intracellular delivery of protein and peptide therapeutics to pharmaceutical and biotechnology companies.

Etherna

This company develops mRNA and lipid nanoparticle technologies for pharmaceutical and biotechnology partners to create nucleic acid-based medicines and vaccines.